• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    1.61 Down 0.10(5.85%) Jan 30, 4:05PM EST
    |After Hours : 1.61 0.00 (0.00%) Jan 30, 4:27PM EST
    Add to Portfolio
    Prev Close:1.71
    Open:1.68
    Bid:1.62 x 800
    Ask:1.67 x 2500
    1y Target Est:4.56
    Beta:1.1
    Earnings Date:Mar 4 - Mar 9 (Est.)
    Day's Range:1.61 - 1.73
    52wk Range:0.97 - 2.12
    Volume:517,065
    Avg Vol (3m):1,260,890
    Market Cap:241.78M
    P/E (ttm):N/A
    EPS (ttm):-0.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NAVB

    Comparison

    Symbol% ChgMkt Cap
    NAVBDown 5.85%241.78M
    LLYDown 0.15%77.97B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):55.68
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.24
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback